This conversation starts with a focus on slowing the growth of the MASLD pandemic, and then veers slightly into a discussion of the specific issues post-menopausal women face with MASLD. 

Roger Green starts by commenting how it seems both pivotally important and highly efficient to find a way to flatten the growth curve, and he asks Zobair what he considers key to doing so.  Zobair replies that the key is to focus on multidisciplinary care centered around primary care, which will require extensive physician education. He also comments that countries may differ widely in what their current MASLD priorities should be. He introduces the idea of the sociodemographic index and the difference between high and low SDI countries. To Zobair, it is critical to elevate the issue of how to support low SDI vs. high SDI countries, which involves, in different ways, every stakeholder from WHO down to patients and their advocates.  

Louise Campbell shifts focus to point out that the article raises a point about the increased risk of MASLD to postmenopausal women. This brings up a range of comments, the most important of which revolve around the need to educate OB/GYN physicians and their allied providers on the important liver risk to post-menopausal women.